Latest 10-K annual reports

NYSE ARCA
VanEck Merk Gold ETF reported a significant 120.85% increase in Net Asset Value to $2.9 billion for the fiscal year ended January 31, 2026, driven by strong gold price appreciation.
NYSE
Andersen Group Inc. reported a 14.6% revenue increase to $838.7 million in 2025, driven by client growth and service expansion, despite a net loss of $(130.2) million primarily due to IPO-related equity restructuring costs.
NYSE
Local Bounti Corporation reported a 27% increase in sales and a significant reduction in net loss for fiscal year 2025, driven by new facility operations and yield enhancements, despite ongoing operating losses and NYSE listing concerns.
BTS
WisdomTree Bitcoin Fund's 2025 annual report reveals a net decrease in assets due to bitcoin price depreciation, despite strong gains in the prior year.
NASDAQ
Intensity Therapeutics' latest 10-K details clinical advancements for its lead cancer drug INT230-6, alongside significant operating losses and ongoing funding needs.
NASDAQ
Innoviva, Inc. filed an amended annual report to include the audited financial statements of its subsidiary, Armata Pharmaceuticals, Inc., which reported substantial losses and a going concern doubt.
NASDAQ
Gyrodyne, LLC, a real estate company focused on property liquidation, has extended its estimated dissolution timeline to December 31, 2028, due to ongoing legal challenges and regulatory delays impacting its Flowerfield and Cortlandt Manor properties.
OQB
Bio Essence Corp. reported a significant turnaround to net income in 2025, driven by a strategic shift to OEM services, despite ongoing litigation and internal control deficiencies.
NYSE
PermRock Royalty Trust reported a significant decline in net profits income and a $39.9 million impairment in 2025, driven by lower oil prices and production volumes, alongside a revised and reduced capital expenditure plan by its operator T2S.
AMEX
Retractable Technologies, Inc. reported a net loss of $12.57 million for fiscal year 2025, impacted by significant tariffs on Chinese imports and material weaknesses in internal controls, despite increased domestic and international sales.
NASDAQ
Bogota Financial Corp. reported a significant rebound to net income in 2025, driven by improved net interest income and strategic balance sheet adjustments, despite a decrease in total assets.
NYSE
San Juan Basin Royalty Trust reports no royalty income or distributions in 2025, accumulating significant Excess Production Costs and raising substantial doubt about its ability to continue as a going concern.
OQB
Quaint Oak Bancorp reports a significant decrease in net income for 2025, driven by lower interest income and higher non-interest expenses, despite growth in total deposits and net loans.
NYSE
Permian Basin Royalty Trust reported a significant increase in proved reserves and settled a lawsuit for $9 million, but distributable income and Waddell Ranch royalties declined sharply in 2025.
AMEX
Serina Therapeutics, Inc. filed an Amendment No. 1 to its 2025 Annual Report on Form 10-K to correct an inadvertently incorrect Auditor Consent and include new certifications from its principal executive and financial officers.
NYSE
Cross Timbers Royalty Trust reports a 13% decrease in 2025 net profits income to $5.74 million, driven by lower oil prices and production, despite higher gas prices.
NASDAQ
Virginia National Bankshares Corporation reported a 13.5% increase in net income for 2025, driven by higher net interest income and improved efficiency, alongside executive transition details.
NASDAQ
BayFirst Financial Corp. reported a net loss of $22.9 million for 2025, driven by increased credit loss provisions and a strategic exit from its nationwide SBA 7(a) lending business.
NASDAQ
Vera Bradley, Inc. reports a net loss of $47.8 million for fiscal 2026, a 23.1% improvement from the prior year, as it executes its Project Sunshine strategy and completes the sale of Pura Vida Bracelets.
AEI Income & Growth Fund XXII Limited Partnership reported a significant increase in net income for 2025 driven by property sales, as it continues its final liquidation process.
AEI Income & Growth Fund XXI Limited Partnership has initiated its final liquidation process, marked by a property sale and a decrease in net asset value per unit in 2025.
NASDAQ
Agriculture & Natural Solutions Acquisition Corporation (ANSC) terminated a prior business combination and extended its deadline to November 2026, facing substantial doubt about its ability to continue as a going concern.
OID
LogicMark, Inc. reported a 15% increase in revenue for fiscal year 2025, reaching $11.4 million, despite an increase in operating losses and a delisting from Nasdaq.
NASDAQ
National Bankshares, Inc. reported a significant increase in net income for 2025, driven by net interest margin expansion and lower credit loss provisions, despite a decrease in total deposits.
NASDAQ
BV Financial, Inc. announced a 15.1% increase in net income to $13.5 million for fiscal year 2025, driven by higher interest income and a significant recovery in credit losses, despite a decrease in stockholders' equity due to substantial stock repurchases.
NASDAQ
Monopar Therapeutics reports progress in its Wilson disease and radiopharmaceutical oncology programs, backed by a recent $91.9 million capital raise and extended cash runway through 2027.
OTC.Pink
Gold Rock Holdings, Inc. reported increased revenues for fiscal year 2025 driven by its AI division, but faces substantial doubt about its ability to continue as a going concern due to accumulated losses and a working capital deficit.
NYSE
Oxford Industries, Inc. reported a net loss of $27.9 million for Fiscal 2025, a significant decline from the prior year, primarily driven by increased tariffs, lower sales, and impairment charges.
OID
Holistic Asset Finance Group Co., Ltd. reported a significant increase in digital marketing revenue for fiscal year 2025, despite ongoing net losses and substantial doubt about its ability to continue as a going concern.
OTC.Pink
iWallet Corporation's annual report reveals a significant increase in net loss for 2025, zero revenue, and substantial doubt about its ability to continue as a going concern, despite progress in product redesign and future sales plans.